Here are four points:
1. Profit Investment Management’s holdings in NuVasive were worth $1.17 million as of its most recent SEC filing.
2. NuVasive has a 12-month low of $36.81 and a 12-month high of $56.61.
3. The stock has a 50-day moving average price of $47.04 and a 200-day moving average price of $50.56.
4. The stock has a market cap of $1.96 billion.
More articles on devices:
FDA to require PMAs for 2 types of metal-on-metal hip replacement devices — 5 takeaways
ACL reconstruction gets virtual reality makeover — 5 insights
HCA, SpineGuard pen national contract — 5 highlights
